The New York Genome Center has appointed Dirk Evers and Kevin Shianna to its leadership team. Evers, who will serve as senior vice president of bioinformatics, joins NYGC from Illumina, where he led the company's computational biology efforts in the UK. Previously, he served as managing director of the International Graduate School in Bioinformatics and Genome Research at the Center for Biotechnology at Bielefeld University. He holds a PhD in natural sciences from Bielefeld University.
Shianna will serve as senior vice president of sequencing operations at the NYGC. He joins from Duke University, where he was an assistant professor in the School of Medicine, director of operations for the Center for Human Genome Variation, and founding director for the Genomic Analysis Facility. He holds a PhD from North Carolina State University.
Source BioScience has made some changes to its board of directors (see related story, this issue). Non-executive director, Robin Slinger, who has been a board member since 2004, has stepped down, and Robert Bakewell has been appointed as a member of the board. Bakewell joined Source Bioscience in 2005 and has served as finance director in a non-board capacity since 2011.